Coherus Biosciences, INC. (CHRS) — DEF 14A Filings
All DEF 14A filings from Coherus Biosciences, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Coherus BioSciences Files DEF 14A for Executive Compensation
— Apr 29, 2025 Risk: low
Coherus BioSciences, Inc. filed a DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and equity -
Coherus BioSciences Files Definitive Proxy Statement
— Apr 15, 2024 Risk:
Coherus BioSciences, Inc. (CHRS) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. Coherus BioSciences, Inc. filed a Definitive Proxy Statement
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX